TargetMol

TargetMol logo

Target Molecule Corp. (TargetMol) is a global high-tech enterprise, specializing in chemical and biological research products and service to meet the research needs of global customers. With the help of fast and efficient global supply chain,professional and rigorous procurement process and timely dynamic news of products, you will save more time with less cost and lead in drug discovery and screening. We are equipped to meet an array of client’s requirements, varying from virtual screening to chemical structure optimization to the provision of commercial products. For further information on our products and services, take a look around our website.

Company Website

Product Listing

(e)-3-(3,4-dihydroxyphenyl)-n-(2-(3,4-dihydroxyphenyl)ethyl)-2-propenamide 1 mg  | Purity Not Available

TargetMol

(e)-3-(3,4-dihydroxyphenyl)-n-(2-(3,4-dihydroxyphenyl)ethyl)-2-propenamide is an organic compound derived from the phenylacrylamide family. It is capable of interacting with proteins and other molecules in a variety of ways and has been used to study protein-protein interactions as well as enzyme-substrate interactions.

More Information Supplier Page

(e)-3-(3,4-dihydroxyphenyl)-n-(2-(3,4-dihydroxyphenyl)ethyl)-2-propenamide 5 mg  | Purity Not Available

TargetMol

(e)-3-(3,4-dihydroxyphenyl)-n-(2-(3,4-dihydroxyphenyl)ethyl)-2-propenamide is an organic compound derived from the phenylacrylamide family. It is capable of interacting with proteins and other molecules in a variety of ways and has been used to study protein-protein interactions as well as enzyme-substrate interactions.

More Information Supplier Page

(e)-3-(3,4-dihydroxyphenyl)-n-(2-(3,4-dihydroxyphenyl)ethyl)-2-propenamide 10 mg  | Purity Not Available

TargetMol

(e)-3-(3,4-dihydroxyphenyl)-n-(2-(3,4-dihydroxyphenyl)ethyl)-2-propenamide is an organic compound derived from the phenylacrylamide family. It is capable of interacting with proteins and other molecules in a variety of ways and has been used to study protein-protein interactions as well as enzyme-substrate interactions.

More Information Supplier Page

(e)-3-(3,4-dihydroxyphenyl)-n-(2-(3,4-dihydroxyphenyl)ethyl)-2-propenamide 25 mg  | Purity Not Available

TargetMol

(e)-3-(3,4-dihydroxyphenyl)-n-(2-(3,4-dihydroxyphenyl)ethyl)-2-propenamide is an organic compound derived from the phenylacrylamide family. It is capable of interacting with proteins and other molecules in a variety of ways and has been used to study protein-protein interactions as well as enzyme-substrate interactions.

More Information Supplier Page

(E)-3-(4-Methoxyphenyl)acrylic acid 500 mg  | 100.00%

TargetMol

(E)-3-(4-Methoxyphenyl)acrylic acid is a small molecule compound isolated from the rhizome of Etlingera pavieana (Pierre ex Gagnep.) R. M. Sm. It is a novel α-glucosidase inhibitor. (E)-3-(4-Methoxyphenyl)acrylic acid has hepatoprotective activity, antiamnesic activity, enhances cognitive effects, and can be used to lower blood pressure sugar.

More Information Supplier Page

(E)-3-(Naphth-1-yl)acrylic acid 500 mg  | Purity Not Available

TargetMol

(E)-3-(Naphth-1-yl)acrylic acid is a biochemical reagent that can be used to synthesize a variety of compounds and participate in many reactions in the body.

More Information Supplier Page

(E)-5-(2-Bromovinyl)uracil 25 mg  | Purity Not Available

TargetMol

(E)-5-(2-Bromovinyl)uracil (BVU) is a pyrimidine base and an inactive metabolite of the antiviral agents sorivudine and (E)-5-(2-bromovinyl)-2′-deoxyuridine (BVDU) that may be regenerated to BVDU in vivo. BVU irreversibly inactivates dihydropyrimidine dehydrogenase (DPD) in an NADPH-dependent manner. It enhances the efficacy of the chemotherapeutic agent and DPD substrate 5-fluorouracil in a P388 murine leukemia model when […]

More Information Supplier Page

(E)-5-(2-Bromovinyl)uracil 50 mg  | Purity Not Available

TargetMol

(E)-5-(2-Bromovinyl)uracil (BVU) is a pyrimidine base and an inactive metabolite of the antiviral agents sorivudine and (E)-5-(2-bromovinyl)-2′-deoxyuridine (BVDU) that may be regenerated to BVDU in vivo. BVU irreversibly inactivates dihydropyrimidine dehydrogenase (DPD) in an NADPH-dependent manner. It enhances the efficacy of the chemotherapeutic agent and DPD substrate 5-fluorouracil in a P388 murine leukemia model when […]

More Information Supplier Page

(E)-5-(2-Bromovinyl)uracil 100 mg  | Purity Not Available

TargetMol

(E)-5-(2-Bromovinyl)uracil (BVU) is a pyrimidine base and an inactive metabolite of the antiviral agents sorivudine and (E)-5-(2-bromovinyl)-2′-deoxyuridine (BVDU) that may be regenerated to BVDU in vivo. BVU irreversibly inactivates dihydropyrimidine dehydrogenase (DPD) in an NADPH-dependent manner. It enhances the efficacy of the chemotherapeutic agent and DPD substrate 5-fluorouracil in a P388 murine leukemia model when […]

More Information Supplier Page